DK178285D0 - Catecholamin-holdig intranasal laegemiddelformulering med forsinket frigivelse af den aktive bestanddel - Google Patents

Catecholamin-holdig intranasal laegemiddelformulering med forsinket frigivelse af den aktive bestanddel

Info

Publication number
DK178285D0
DK178285D0 DK178285A DK178285A DK178285D0 DK 178285 D0 DK178285 D0 DK 178285D0 DK 178285 A DK178285 A DK 178285A DK 178285 A DK178285 A DK 178285A DK 178285 D0 DK178285 D0 DK 178285D0
Authority
DK
Denmark
Prior art keywords
catecholamine
active ingredient
pharmaceutical formulation
delayed release
intranasal pharmaceutical
Prior art date
Application number
DK178285A
Other languages
English (en)
Other versions
DK178285A (da
Inventor
Kristina Marie Campanale
Kenneth Shyan-Ell Su
Harve Clark Wilson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK178285D0 publication Critical patent/DK178285D0/da
Publication of DK178285A publication Critical patent/DK178285A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK178285A 1984-04-25 1985-04-22 Catecholamin-holdig intranasal laegemiddelformulering med forsinket frigivelse af den aktive bestanddel DK178285A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60380884A 1984-04-25 1984-04-25
US06/695,491 US4581225A (en) 1984-04-25 1985-01-28 Sustained release intranasal formulation and method of use thereof

Publications (2)

Publication Number Publication Date
DK178285D0 true DK178285D0 (da) 1985-04-22
DK178285A DK178285A (da) 1985-10-26

Family

ID=27084522

Family Applications (1)

Application Number Title Priority Date Filing Date
DK178285A DK178285A (da) 1984-04-25 1985-04-22 Catecholamin-holdig intranasal laegemiddelformulering med forsinket frigivelse af den aktive bestanddel

Country Status (8)

Country Link
US (1) US4581225A (da)
EP (1) EP0160501A3 (da)
AU (1) AU570555B2 (da)
CA (1) CA1241918A (da)
DK (1) DK178285A (da)
IL (1) IL74954A (da)
NZ (1) NZ211835A (da)
PH (1) PH21194A (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
DE3640544A1 (de) * 1986-11-27 1988-06-01 Goedecke Ag Norfenefrin enthaltende pharmazeutische zubereitungsform
US5179079A (en) * 1986-12-16 1993-01-12 Novo Nordisk A/S Nasal formulation and intranasal administration therewith
JPH02503672A (ja) * 1987-06-01 1990-11-01 ワーナー‐ランバート・コンパニー 水性の系における浸透促進剤としての脂肪酸およびその短鎖エステル
EP0348507A4 (en) * 1987-12-23 1990-12-27 Poltav Med Stomatolog Inst Pharmaceutical preparation for individual prophylaxis of venereal diseases and curing urogenital trichomoniasis
US5248493A (en) * 1988-08-27 1993-09-28 Fisons Plc Pharmaceutical composition
US5246949A (en) * 1989-12-06 1993-09-21 Sansho Co., Ltd. Preparation for endermism containing dopamine derivatives
BR9105371A (pt) * 1990-12-20 1992-08-25 Lilly Co Eli Formulacao apropriada para a administracao transdermica de dobutamina e processo para aumentar a contratilidade cardiaca
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
DE4218291A1 (de) * 1992-06-03 1993-12-09 Mattern Et Partner Pharmazeuti Dosierspray für pernasale Applikation
US5756071A (en) * 1992-06-03 1998-05-26 Arrowdean Limited Method for nasally administering aerosols of therapeutic agents to enhance penetration of the blood brain barrier
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
TW431888B (en) * 1994-02-03 2001-05-01 Schering Plough Healthcare Nasal spray compositions
ES2154710T3 (es) * 1994-12-16 2001-04-16 Hoechst Trevira Gmbh & Co Kg Hilo hibrido y material textil deformable permanentemente encogible y encogido, fabricado a partir del mismo, su fabricacion y utilizacion.
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
ES2258694T3 (es) * 2003-11-11 2006-09-01 Mattern, Udo Sistema de administracion de liberacion controlada de hormonas sexuales para aplicaciones nasales.
US20050226929A1 (en) * 2004-04-12 2005-10-13 Jianbo Xie Controlled release opioid analgesic formulation
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
GB2437488A (en) * 2006-04-25 2007-10-31 Optinose As Pharmaceutical oily formulation for nasal or buccal administration
CA2664427C (en) * 2006-10-04 2012-06-05 M & P Patent Aktiengesellschaft Controlled release delivery system for nasal application of neurotransmitters
US20130040923A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
US20200085765A1 (en) * 2014-07-03 2020-03-19 Darren Rubin Safer and more effective methods of transmucosal, including intranasal, delivery for raising blood pressure and stimulating the body

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2222976A (en) * 1937-11-15 1940-11-26 Sharp & Dohme Inc Nasal drops
US2196322A (en) * 1937-12-04 1940-04-09 Squibb & Sons Inc Pharmaceutical
BE556587A (da) * 1957-01-31 1957-04-11
US3069319A (en) * 1959-10-14 1962-12-18 American Cyanamid Co Sprayable composition
NL262354A (da) * 1960-03-17
US3282781A (en) * 1960-11-25 1966-11-01 Merck & Co Inc Inhalant compositions
US3106511A (en) * 1961-12-14 1963-10-08 Revlon Amyl nitrite inhalant composition
US3159535A (en) * 1962-01-31 1964-12-01 Johnson & Son Inc S C Aerosol compositions
BE632504A (da) * 1962-05-24
NL289785A (da) * 1962-11-29
US3406237A (en) * 1962-11-30 1968-10-15 Boehringer Sohn Ingelheim Composition and a method for relieving broncho-spasms which use 1-p-hydroxyphenyl - 2 - (beta - 3',5' - dihydroxyphenyl - beta-hydroxy)-ethylaminopropane
US3304230A (en) * 1963-02-18 1967-02-14 Revlon Liquid aerosol propellant solutions of fatty acid salts of physiologically active amines
US3320125A (en) * 1964-04-28 1967-05-16 Merck & Co Inc Inhalation aerosol composition
GB1114313A (en) * 1964-11-19 1968-05-22 Wyeth John & Brother Ltd Pharmaceutical compositions
US3419658A (en) * 1965-01-25 1968-12-31 Du Pont Nonaqueous aerosol foams containing mineral oil
US3482015A (en) * 1965-02-08 1969-12-02 Merck & Co Inc Aerosol composition of phenylephrine tartrate and the production of such
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
SE335359B (da) * 1966-10-19 1971-05-24 Draco Ab
US4001391A (en) * 1969-04-18 1977-01-04 Plough, Inc. Means for depositing aerosol sprays in buttery form
US3608065A (en) * 1969-09-11 1971-09-21 Merck & Co Inc Aerosol composition containing a vasoconstrictor
CA982942A (en) * 1970-03-20 1976-02-03 Herbert Lapidus Aerosol nasal spray composition
BE786200A (fr) * 1971-07-13 1973-01-12 Boehringer Sohn Ingelheim Traitement par inhalation de maladies bronchiques
US3987200A (en) * 1972-04-12 1976-10-19 Eli Lilly And Company Method for increasing cardiac contractility
US4175128A (en) * 1979-01-03 1979-11-20 Pfizer Inc. Method for treating congestive heart failure
DE2903957A1 (de) * 1979-02-02 1980-08-07 Boehringer Sohn Ingelheim Mittel zur behandlung der nasalen hypersekretion
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol

Also Published As

Publication number Publication date
CA1241918A (en) 1988-09-13
IL74954A (en) 1988-05-31
NZ211835A (en) 1988-02-12
PH21194A (en) 1987-08-19
AU570555B2 (en) 1988-03-17
AU4161685A (en) 1985-10-31
EP0160501A2 (en) 1985-11-06
US4581225A (en) 1986-04-08
DK178285A (da) 1985-10-26
EP0160501A3 (en) 1986-12-30

Similar Documents

Publication Publication Date Title
DK178285A (da) Catecholamin-holdig intranasal laegemiddelformulering med forsinket frigivelse af den aktive bestanddel
DK98088D0 (da) Farmaceutisk formulering med forsinket frigivelse af den aktive bestanddel
DK392281A (da) Pestcide midler med langsom frigorelse af den aktive bestanddel
NO861481L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive heterocykliske amid-derivater.
DK263288A (da) Farmaceutisk praeparat af cefuroxim-axetil
DE10075031I1 (de) Zusammensetzung zur kontrolierten Abgabe eines Wirkstoffs
FI890238A7 (fi) Aktiivista ainetta ohjelmoidusti vapauttavia galeenisia koostumuksia
DE59003337D1 (de) Pressling mit retardierter Wirkstofffreisetzung.
FI864700A0 (fi) Reglering av vridmomentet hos vindturbin med foeraenderlig hastighet.
DK324385A (da) Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof
DK147386D0 (da) Derivater af methylen-bisphosphonsyre, fremgangsmaade til fremstillingaf samme samt farmaceutisk sammensaetning
KR920701213A (ko) 메틸렌디포스폰산 화합물 및 그것을 유효성분으로 하는 항염증제
DK386986D0 (da) Injicerbar halvfast farmaceutisk formulering med langsom frigivelse af den aktive bestanddel
DK396286A (da) Injicerbar formulering med forsinket frigivelse af den aktive bestanddel
DK165984C (da) Fremgangsmaade til fremstilling af sphingosinderivater
DE69518193D1 (de) Präparat mit verzörgerter Wirkstoffabgabe
DK100289D0 (da) Fremgangsmaade til fremstilling af n-sulfonylurinstoffer
DK73980A (da) Insecticidt eller nematodicidt granulat med forhalet frigoerelse af den aktive bestanddel
DK537687A (da) Fremgangsmaade til fremstilling af n-substituerede piperazinoner
DK38493D0 (da) Fremgangsmaade til fremstilling af alkoxymethylether- og alkoxymethylesterderivater af glyceroler
DK516286D0 (da) Fremgangsmaade til fremstilling af oxazolderivater
DK164785C (da) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner, deres fremstilling og deres anvendelse til fremstilling af antipedressive midler
DK314988A (da) Fremgangsmaade til fremstilling af 6-deoxyguaninderivater
DK574688D0 (da) Fremgangsmaade til fremstilling af propensyrederivater
DK498388A (da) Fremgangsmaade til fremstilling af propensyrederivater

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment